|
|
|
| ZHANG Liang,FENG Li,ZHAO Xiao-ping,FAN Zhong-yi |
|
|
|
|
|
|
Received: 03 November 2012
|
|
Corresponding Authors:
FAN Zhong-yi
|
|
|
|
| [1] |
Glorieux FH. Osteogenesis imperfecta. Best Pract Res Clin Rheumatol，2008，22：85-100.
|
| [2] |
Sillence DO， Senn A， Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet，1979，16：101-116.
|
| [3] |
Lin HY， Lin SP， Chuang CK， et al. Intravenous pamidronate therapy in Taiwanese patients with osteogenesis imperfecta. Pediatr Neonatol，2008，49：161-165.
|
| [4] |
Bajpai A， Kabra M， Gupta N， et al. Intravenous pamidronate therapy in osteogenesis imperfecta： response to treatment and factors influencing outcome. J Pediatr Orthop，2007，27：225-227.
|
| [5] |
Zack P， Zack LR， Surtees R， et al. A standardized tool to measure and describe scleral colour in osteogenesis imperfecta. Ophthalmic Physiol Opt，2007，27：174-178.
|
| [6] |
Sillence D， Butler B， Latham M， et al. Natural history of blue sclerae in osteogenesis imperfecta. Am J Med Genet，1993，45：183-186.
|
| [1] |
. [J]. Chinese Journal of Optometry Ophthalmology and Visual science, 2023, 25(8): 0-. |
|
|
|
|
